miR-383-5p serves as a tumor suppressor in bladder cancer by suppressing PI3K/AKT signaling pathway

被引:6
作者
Liu, Yu [1 ,2 ]
Yu, Haitao [1 ]
Zeng, Bin [3 ]
Gou, Xin [1 ]
Ren, Ke [1 ]
Yuan, Fangchao [1 ]
机构
[1] Chongqing Med Univ, Dept Urol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China
[2] Chongqing Tradit Chinese Med Hosp, Dept Urol, Chongqing, Peoples R China
[3] Chongqing Med Univ, Dept Breast & Thyroid Surg, Affiliated Hosp 2, Chongqing, Peoples R China
关键词
miR-383-5p; PI3KR1; AKT; bladder cancer; PROLIFERATION; MICRORNAS; MIGRATION; CELLS;
D O I
10.3233/CBM-220379
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: MicroRNAs have been proven to be key molecules in human malignancy. However, to our knowledge, there is no study reporting miR-383-5p expression level and the role it plays in bladder cancer (BC). METHODS: We identified miR-383-5p to be one of the tumor-suppressing genes through using data from The Cancer Genome Atlas (TCGA) and GEO database. We evaluate the expression and activity of miR-383-5p in both BC tissue and cell lines. The impacts of miR-383-5p on proliferative, migratory ability and apoptotic rate in BC cell were evaluated by utilizing CCK-8 kits, flow cytometry, and Transwell assays. qRT-PCR, western blot, and luciferase reporter assays have been adopted to investigate the underlying mechanisms. In vivo tumorigenicity testing was conducted to determine the impact of miR-383-5p on BC cellular proliferative capacity. RESULTS: Reduced miR-383-5p expression has been determined in BC tissue than in normal bladder tissue. Furthermore, BC cell proliferative, migratory ability was inhibited while apoptosis enhanced in vitro and in vivo by miR-383-5p up-regulation. In vitro and in vivo, silencing miR-383-5p considerably improved the growth and invasive capacity of cell, while decreased the apoptotic rates of BC cells. CONCLUSION: miR-383-5p plays its role as a tumor-suppressing gene by suppressing the PI3K/AKT signaling, hence preventing the development of BC.
引用
收藏
页码:121 / 131
页数:11
相关论文
共 28 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
[3]   MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer [J].
Bucay, N. ;
Sekhon, K. ;
Yang, T. ;
Majid, S. ;
Shahryari, V. ;
Hsieh, C. ;
Mitsui, Y. ;
Deng, G. ;
Tabatabai, Z. L. ;
Yamamura, S. ;
Calin, G. A. ;
Dahiya, R. ;
Tanaka, Y. ;
Saini, S. .
ONCOGENE, 2017, 36 (19) :2667-2679
[4]   microRNA: diagnostic perspective [J].
Faruq, Omar ;
Vecchione, Andrea .
FRONTIERS IN MEDICINE, 2015, 2
[5]  
Gu B., 2018, J CELL BIOCHEM
[6]   MicroRNAs in cancer: biomarkers, functions and therapy [J].
Hayes, Josie ;
Peruzzi, Pier Paolo ;
Lawler, Sean .
TRENDS IN MOLECULAR MEDICINE, 2014, 20 (08) :460-469
[7]   Bladder Cancer in 2010 How Far Have We Come? [J].
Jacobs, Bruce L. ;
Lee, Cheryl T. ;
Montie, James E. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2010, 60 (04) :244-272
[8]   Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27 [J].
Jiang, Jing ;
Xie, Chuanmei ;
Liu, Yujuan ;
Shi, Qi ;
Chen, Yan .
BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 :595-601
[9]   A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes [J].
Kent, O. A. ;
Mendell, J. T. .
ONCOGENE, 2006, 25 (46) :6188-6196
[10]   Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity [J].
Knowles, Margaret A. ;
Hurst, Carolyn D. .
NATURE REVIEWS CANCER, 2015, 15 (01) :25-41